Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
A blood donation center. Photo: Andrew Milligan/PA Images via Getty Images
Ambrosia, a company that injects young people’s blood into older people, says it is now up and running in five American cities, the company tells Business Insider. Filling your aged veins with one liter of a younger person’s blood costs $8,000 — and two liters is a steal at $12,000.
The big picture: This whole blood-replacement thing is marketed as an anti-aging treatment. But, as Business Insider notes, there’s essentially no evidence it has any medical benefit, and it has raised plenty of red flags along the way. Ambrosia recently completed a clinical trial of its procedure, but hasn’t published the results yet.